ReviewInternational journal of molecular sciences2021

Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy.

Giorgio Valabrega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.